• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过共表达分析确定,拓扑异构酶2α的过表达预示着胰腺腺癌的预后不良。

Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.

作者信息

Zhou Zhou, Liu Shi, Zhang Meng, Zhou Rui, Liu Jing, Chang Ying, Zhao Qiu

机构信息

Department of Gastroenterology, Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430071, Hubei Province, People's Republic of China.

出版信息

Dig Dis Sci. 2017 Oct;62(10):2790-2800. doi: 10.1007/s10620-017-4718-4. Epub 2017 Aug 16.

DOI:10.1007/s10620-017-4718-4
PMID:28815403
Abstract

BACKGROUND

Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of human cancer-related death in the developed countries. Its progression and prognosis are influenced by a complex network of gene interactions.

AIMS

The purpose of this study is to explore key genes associated with pancreatic ductal adenocarcinoma and to predict the possible mechanisms.

METHODS

A weighted gene co-expression network was constructed to identify gene modules associated with the progression of PDAC.

RESULTS

In the significant module (R  = 0.30), a total of 20 network hub genes were identified, 6 of which were also hub nodes in the protein-protein interaction network of the module genes. In validation, TOP2A has a higher correlation than other hub genes. Also, in the test set (n = 118), TOP2A was more highly expressed in PDAC than normal pancreas samples (P < 0.001). What is more, gene set enrichment analysis demonstrated that eight gene sets (n = 118), "nucleotide excision repair," "P53 signaling pathway," "proteasome," "mismatch repair," "homologous recombination," "DNA replication," "cell cycle," and "base excision repair," were enriched (FDR < 0.05). In gene ontology analysis, TOP2A in the enriched set was associated with cell cycle and cell division. Furthermore, survival analysis indicated that higher expression of TOP2A resulted in the lower overall survival time as well as disease-free survival time.

CONCLUSION

TOP2A was identified in association with the progression and prognosis of PDAC probably by regulating cell cycle and p53 signaling pathway.

摘要

背景

胰腺导管腺癌(PDAC)是发达国家中人类癌症相关死亡的第四大常见原因。其进展和预后受复杂的基因相互作用网络影响。

目的

本研究旨在探索与胰腺导管腺癌相关的关键基因,并预测可能的机制。

方法

构建加权基因共表达网络以识别与PDAC进展相关的基因模块。

结果

在显著模块(R = 0.30)中,共鉴定出20个网络中心基因,其中6个也是模块基因蛋白质 - 蛋白质相互作用网络中的中心节点。在验证中,TOP2A的相关性高于其他中心基因。此外,在测试集(n = 118)中,TOP2A在PDAC中的表达高于正常胰腺样本(P < 0.001)。而且,基因集富集分析表明八个基因集(n = 118),即“核苷酸切除修复”、“P53信号通路”、“蛋白酶体”、“错配修复”、“同源重组”、“DNA复制”、“细胞周期”和“碱基切除修复”被富集(FDR < 0.05)。在基因本体分析中,富集集中的TOP2A与细胞周期和细胞分裂相关。此外,生存分析表明TOP2A的高表达导致总生存时间和无病生存时间降低。

结论

TOP2A可能通过调节细胞周期和p53信号通路与PDAC的进展和预后相关。

相似文献

1
Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.通过共表达分析确定,拓扑异构酶2α的过表达预示着胰腺腺癌的预后不良。
Dig Dis Sci. 2017 Oct;62(10):2790-2800. doi: 10.1007/s10620-017-4718-4. Epub 2017 Aug 16.
2
[Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].[拓扑异构酶IIα和HER2/neu基因改变及其在胰腺导管腺癌中的相关性]
Zhonghua Bing Li Xue Za Zhi. 2007 Feb;36(2):102-6.
3
Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.通过生物信息学分析鉴定与胰腺导管腺癌预后不良相关的新基因。
Biosci Rep. 2019 Aug 2;39(8). doi: 10.1042/BSR20190625. Print 2019 Aug 30.
4
Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis.通过共表达分析鉴定与胰腺导管腺癌 T 分期和预后相关的潜在四 miRNA 特征。
Mol Med Rep. 2019 Jan;19(1):441-451. doi: 10.3892/mmr.2018.9663. Epub 2018 Nov 19.
5
Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的综合临床病理特征及基因芯片分析
Gene. 2017 Aug 20;625:72-77. doi: 10.1016/j.gene.2017.05.009. Epub 2017 May 4.
6
Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays.胰腺导管腺癌中拓扑异构酶IIa表达的评估:一项在组织微阵列上使用显色原位杂交和免疫组织化学的初步研究。
Pancreatology. 2007;7(1):45-52. doi: 10.1159/000101877. Epub 2007 Apr 18.
7
Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.通过加权基因共表达网络分析鉴定胰腺导管腺癌的候选 miRNA 生物标志物
Cell Oncol (Dordr). 2017 Apr;40(2):181-192. doi: 10.1007/s13402-017-0315-y. Epub 2017 Feb 15.
8
Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.非小细胞肺癌相关潜在机制的研究。
J Comput Biol. 2020 Sep;27(9):1433-1442. doi: 10.1089/cmb.2019.0081. Epub 2020 Feb 12.
9
Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.通过多维系统水平分析鉴定胰腺癌进展的关键调节因子。
Genome Med. 2016 May 3;8(1):38. doi: 10.1186/s13073-016-0282-3.
10
SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis.SERP1 通过抗细胞凋亡和调控 SRPRB/NF-κB 轴成为胰腺导管腺癌患者预后不良的新型标志物。
Int J Oncol. 2017 Oct;51(4):1104-1114. doi: 10.3892/ijo.2017.4111. Epub 2017 Aug 31.

引用本文的文献

1
CDCP1-targeting ADC outperforms standard therapies in Ras-mutant pancreatic cancer.靶向CDCP1的抗体偶联药物在Ras突变型胰腺癌中优于标准疗法。
Mol Ther Oncol. 2025 Jul 21;33(3):201024. doi: 10.1016/j.omton.2025.201024. eCollection 2025 Sep 18.
2
Predicting severity of inpatient acute cholangitis: combined neutrophil-to-lymphocyte ratio and prognostic nutritional index.预测住院患者急性胆管炎的严重程度:中性粒细胞与淋巴细胞比值和预后营养指数联合应用
BMC Gastroenterol. 2024 Dec 20;24(1):468. doi: 10.1186/s12876-024-03560-w.
3
Integrated bioinformatics reveals genetic links between visceral obesity and uterine tumors.

本文引用的文献

1
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.GEPIA:一个用于癌症和正常基因表达谱分析及交互式分析的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102. doi: 10.1093/nar/gkx247.
2
Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.UGT1A1基因多态性及ERCC1、BRCA1、TYMS、RRM1、TUBB3、STMN1和TOP2A在胃癌中的表达的临床意义
BMC Gastroenterol. 2017 Jan 5;17(1):2. doi: 10.1186/s12876-016-0561-x.
3
Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.
综合生物信息学揭示内脏肥胖与子宫肿瘤之间的遗传关联。
Mol Genet Genomics. 2024 Oct 5;299(1):93. doi: 10.1007/s00438-024-02184-9.
4
The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway.POLE2 预后枢纽基因通过 PI3K/AKT 信号通路促进膀胱癌细胞生长。
Comb Chem High Throughput Screen. 2024;27(13):1984-1998. doi: 10.2174/0113862073273633231113060429.
5
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma.BAR502的发现,一种用于治疗胰腺腺癌的白血病抑制因子受体强效甾体拮抗剂。
Front Oncol. 2023 Mar 14;13:1140730. doi: 10.3389/fonc.2023.1140730. eCollection 2023.
6
Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network.通过加权基因共表达网络识别人类间变性甲状腺癌的关键基因。
Biomed Res Int. 2022 Jun 23;2022:2244228. doi: 10.1155/2022/2244228. eCollection 2022.
7
Identification of key protein-coding genes in lung adenocarcinomas based on bioinformatic analysis.基于生物信息学分析鉴定肺腺癌中的关键蛋白质编码基因
Transl Cancer Res. 2019 Dec;8(8):2829-2840. doi: 10.21037/tcr.2019.10.45.
8
Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics.预后相关基因在胰腺肿瘤转移中的意义:生物信息学全球研究的启示。
Cancer Metastasis Rev. 2021 Sep;40(3):721-738. doi: 10.1007/s10555-021-09991-1. Epub 2021 Sep 30.
9
Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.基于 WGCNA 的预后相关 lncRNAs 筛选,建立预测肝细胞癌患者预后的新风险评分模型。
J Immunol Res. 2021 Aug 14;2021:5518908. doi: 10.1155/2021/5518908. eCollection 2021.
10
Identification of Biomarkers for Predicting Allograft Rejection following Kidney Transplantation Based on the Weighted Gene Coexpression Network Analysis.基于加权基因共表达网络分析的肾移植后移植物排斥反应预测的生物标志物鉴定。
Biomed Res Int. 2021 Jul 29;2021:9933136. doi: 10.1155/2021/9933136. eCollection 2021.
基于量子点的三阴性乳腺癌中TOP2A免疫荧光成像、定量检测及预后价值
Int J Nanomedicine. 2016 Oct 21;11:5519-5529. doi: 10.2147/IJN.S111594. eCollection 2016.
4
p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress.p53 控制 CDC7 的水平,以在基因毒性应激时加强 G1 期细胞周期阻滞。
Cell Cycle. 2016 Nov;15(21):2958-2972. doi: 10.1080/15384101.2016.1231281. Epub 2016 Sep 9.
5
SVD-phy: improved prediction of protein functional associations through singular value decomposition of phylogenetic profiles.SVD-phy:通过系统发育谱的奇异值分解改进蛋白质功能关联预测
Bioinformatics. 2016 Apr 1;32(7):1085-7. doi: 10.1093/bioinformatics/btv696. Epub 2015 Nov 26.
6
p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis.p53:除了对细胞周期和细胞凋亡的影响之外,p53 还能预防肿瘤生长。
Cancer Res. 2015 Dec 1;75(23):5001-7. doi: 10.1158/0008-5472.CAN-15-0563. Epub 2015 Nov 16.
7
Molecular detection of pancreatic neoplasia: Current status and future promise.胰腺肿瘤的分子检测:现状与未来前景
World J Gastroenterol. 2015 Oct 28;21(40):11387-95. doi: 10.3748/wjg.v21.i40.11387.
8
MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.微小RNA-138-5p通过靶向FOXC1调节胰腺癌细胞的生长。
Cell Oncol (Dordr). 2015 Jun;38(3):173-81. doi: 10.1007/s13402-014-0200-x. Epub 2015 Feb 10.
9
Proteomics. Tissue-based map of the human proteome.蛋白质组学。人类蛋白质组组织图谱。
Science. 2015 Jan 23;347(6220):1260419. doi: 10.1126/science.1260419.
10
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.Top2a为侵袭性前列腺癌的新型联合治疗策略确定并提供了表观遗传学依据。
Oncotarget. 2015 Feb 20;6(5):3136-46. doi: 10.18632/oncotarget.3077.